Poor Actelion. If Amen acquires them, they must have been $hit all along like Synergen, Immunex, Kinetix, Tularik, Abgenix and the last two which were so insignificant and totally forgettable. Somebody (KS) just wants to buy a Swiss chalet with shareholder's money. This must be Brainwave's baby, too. He can operate the drawbridge.
This looks like the beginning of another disaster in the making. From what I've read, it looks as if the only money-making drug that Actelion has is about to go off patent starting in just 5 years. It's hard to believe that so many supposedly smart fund managers have so much tied up in this company. This is the most disappointing stock I've ever owned in nearly 50 years of investing. Thanks, Kevin!